BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 27789729)

  • 1. Single versus double antiplatelet therapy in patients undergoing coronary artery bypass grafting with coronary endarterectomy: mid-term results and clinical implications.
    Russo M; Nardi P; Saitto G; Bovio E; Pellegrino A; Scafuri A; Ruvolo G
    Interact Cardiovasc Thorac Surg; 2017 Feb; 24(2):203-208. PubMed ID: 27789729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of dual antiplatelet therapies after coronary endarterectomy combined with coronary artery bypass grafting: a cohort study.
    Yan H; Tiemuerniyazi X; Song Y; Xu F; Feng W
    J Cardiothorac Surg; 2020 Jun; 15(1):155. PubMed ID: 32600365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The midterm results of coronary endarterectomy in patients with diffuse coronary artery disease.
    Qiu Z; Auchoybur Merveesh L; Xu Y; Jiang Y; Wang L; Xu M; Xiang F; Chen X
    J Cardiothorac Surg; 2018 Jul; 13(1):90. PubMed ID: 30041678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial.
    Gao G; Zheng Z; Pi Y; Lu B; Lu J; Hu S
    J Am Coll Cardiol; 2010 Nov; 56(20):1639-43. PubMed ID: 21050973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG: FREEDOM Insights.
    van Diepen S; Fuster V; Verma S; Hamza TH; Siami FS; Goodman SG; Farkouh ME
    J Am Coll Cardiol; 2017 Jan; 69(2):119-127. PubMed ID: 28081820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) Trial.
    Kulik A; Le May MR; Voisine P; Tardif JC; Delarochelliere R; Naidoo S; Wells GA; Mesana TG; Ruel M
    Circulation; 2010 Dec; 122(25):2680-7. PubMed ID: 21135365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eight-year follow-up of the Clopidogrel After Surgery for Coronary Artery Disease (CASCADE) trial.
    Hage A; Voisine P; Erthal F; Larose É; Glineur D; Chow B; Tremblay H; Fortier J; Ko G; Une D; Farkouh M; Mesana TG; LeMay M; Kulik A; Ruel M
    J Thorac Cardiovasc Surg; 2018 Jan; 155(1):212-222.e2. PubMed ID: 28734623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced antiplatelet therapy after drug-eluting stenting: multicenter Janus Flex carbostent implantation with short dual antiplatelet treatment for 2 or 6 months-MATRIX study.
    Cassese S; De Luca G; Villari B; Berti S; Bellone P; Alfieri A; Montinaro A; Quaranta G; Marraccini P; Piscione F;
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):408-16. PubMed ID: 21735531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clopidogrel and aspirin versus clopidogrel alone on graft patency after coronary artery bypass grafting.
    Gao C; Ren C; Li D; Li L
    Ann Thorac Surg; 2009 Jul; 88(1):59-62. PubMed ID: 19559191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study.
    Sun JC; Teoh KH; Lamy A; Sheth T; Ellins ML; Jung H; Yusuf S; Anand S; Connolly S; Whitlock RP; Eikelboom JW
    Am Heart J; 2010 Dec; 160(6):1178-84. PubMed ID: 21146675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial.
    Une D; Al-Atassi T; Kulik A; Voisine P; Le May M; Ruel M
    Circulation; 2014 Sep; 130(11 Suppl 1):S12-8. PubMed ID: 25200049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Chen KY; Rha SW; Li YJ; Poddar KL; Jin Z; Minami Y; Wang L; Kim EJ; Park CG; Seo HS; Oh DJ; Jeong MH; Ahn YK; Hong TJ; Kim YJ; Hur SH; Seong IW; Chae JK; Cho MC; Bae JH; Choi DH; Jang YS; Chae IH; Kim CJ; Yoon JH; Chung WS; Seung KB; Park SJ;
    Circulation; 2009 Jun; 119(25):3207-14. PubMed ID: 19528339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Short-term outcomes of triple antiplatelet therapy after percutaneous coronary intervention].
    Han YL; Su QF; Li Y; Wang SL; Jing QM; Ma YY; Wang ZL; Wang DM; Luan B
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1093-6. PubMed ID: 16796832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
    Fox KA; Mehta SR; Peters R; Zhao F; Lakkis N; Gersh BJ; Yusuf S;
    Circulation; 2004 Sep; 110(10):1202-8. PubMed ID: 15313956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
    Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
    JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of dual antiplatelet therapy after coronary artery bypass surgery on 1-year outcomes in the Arterial Revascularization Trial.
    Benedetto U; Altman DG; Gerry S; Gray A; Lees B; Flather M; Taggart DP;
    Eur J Cardiothorac Surg; 2017 Sep; 52(3):456-461. PubMed ID: 28387790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term clinical efficacy and safety of adding cilostazol to dual antiplatelet therapy for patients undergoing PCI: a meta-analysis of randomized trials with adjusted indirect comparisons.
    Chen Y; Zhang Y; Tang Y; Huang X; Xie Y
    Curr Med Res Opin; 2014 Jan; 30(1):37-49. PubMed ID: 24083626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative clopidogrel improves mid-term outcome after off-pump coronary artery bypass graft surgery: a prospective study.
    Gurbuz AT; Zia AA; Vuran AC; Cui H; Aytac A
    Eur J Cardiothorac Surg; 2006 Feb; 29(2):190-5. PubMed ID: 16388957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.
    Feres F; Costa RA; Abizaid A; Leon MB; Marin-Neto JA; Botelho RV; King SB; Negoita M; Liu M; de Paula JE; Mangione JA; Meireles GX; Castello HJ; Nicolela EL; Perin MA; Devito FS; Labrunie A; Salvadori D; Gusmão M; Staico R; Costa JR; de Castro JP; Abizaid AS; Bhatt DL;
    JAMA; 2013 Dec; 310(23):2510-22. PubMed ID: 24177257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin plus clopidogrel for optimal platelet inhibition following off-pump coronary artery bypass surgery: results from the CRYSSA (prevention of Coronary arteRY bypaSS occlusion After off-pump procedures) randomised study.
    Mannacio VA; Di Tommaso L; Antignan A; De Amicis V; Vosa C
    Heart; 2012 Dec; 98(23):1710-5. PubMed ID: 22942294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.